These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39197915)

  • 21. Update on Accelerated Whole Breast Irradiation.
    Shah C; Fleming-Hall E; Asha W
    Clin Breast Cancer; 2023 Apr; 23(3):237-240. PubMed ID: 36792457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects.
    Guenzi M; Vagge S; Azinwi NC; D'Alonzo A; Belgioia L; Garelli S; Gusinu M; Corvò R
    Radiat Oncol; 2010 Nov; 5():111. PubMed ID: 21092219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Final Analysis of a Phase 2 Trial of Once Weekly Hypofractionated Whole Breast Irradiation for Early-Stage Breast Cancer.
    Reshko LB; Pan J; Rai SN; Ajkay N; Dragun A; Roberts TL; Riley EC; Quillo AR; Scoggins CR; McMasters KM; Eldredge-Hindy H
    Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):56-65. PubMed ID: 34710520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase 2 trial of accelerated, hypofractionated whole-breast irradiation of 39 Gy in 13 fractions followed by a tumor bed boost sequentially delivering 9 Gy in 3 fractions in early-stage breast cancer.
    Kim JY; Jung SY; Lee S; Kang HS; Lee ES; Park IH; Lee KS; Ro J; Lee NK; Shin KH
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1037-42. PubMed ID: 24267970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of two radiation boost schedules in postlumpectomy patients with breast cancer.
    Yadav BS; Sharma SC; Singh G; Dahiya D
    J Cancer Res Ther; 2020; 16(6):1344-1349. PubMed ID: 33342794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypofractionated radiotherapy after breast-conserving surgery: Clinical and dosimetric factors predictive of acute skin toxicity.
    Ben Amor R; Bohli M; Naimi Z; Aissaoui D; Mejri N; Yahyaoui J; Hamdoun A; Kochbati L
    Strahlenther Onkol; 2023 Jan; 199(1):48-54. PubMed ID: 35943552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.
    Haviland JS; Owen JR; Dewar JA; Agrawal RK; Barrett J; Barrett-Lee PJ; Dobbs HJ; Hopwood P; Lawton PA; Magee BJ; Mills J; Simmons S; Sydenham MA; Venables K; Bliss JM; Yarnold JR;
    Lancet Oncol; 2013 Oct; 14(11):1086-1094. PubMed ID: 24055415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline.
    Smith BD; Bentzen SM; Correa CR; Hahn CA; Hardenbergh PH; Ibbott GS; McCormick B; McQueen JR; Pierce LJ; Powell SN; Recht A; Taghian AG; Vicini FA; White JR; Haffty BG
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):59-68. PubMed ID: 20638191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.
    Chua BH; Link EK; Kunkler IH; Whelan TJ; Westenberg AH; Gruber G; Bryant G; Ahern V; Purohit K; Graham PH; Akra M; McArdle O; O'Brien P; Harvey JA; Kirkove C; Maduro JH; Campbell ID; Delaney GP; Martin JD; Vu TTT; Muanza TM; Neal A; Olivotto IA;
    Lancet; 2022 Aug; 400(10350):431-440. PubMed ID: 35934006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
    Murray Brunt A; Haviland JS; Wheatley DA; Sydenham MA; Alhasso A; Bloomfield DJ; Chan C; Churn M; Cleator S; Coles CE; Goodman A; Harnett A; Hopwood P; Kirby AM; Kirwan CC; Morris C; Nabi Z; Sawyer E; Somaiah N; Stones L; Syndikus I; Bliss JM; Yarnold JR;
    Lancet; 2020 May; 395(10237):1613-1626. PubMed ID: 32580883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Has Hypofractionated Whole-Breast Radiation Therapy Become the Standard of Care in the United States? An Updated Report from National Cancer Database.
    Kang MM; Hasan Y; Waller J; Saulsberry L; Huo D
    Clin Breast Cancer; 2022 Jan; 22(1):e8-e20. PubMed ID: 34257001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of Radiation Induced Pneumonitis and Pericarditis in Patients Undergoing Breast Conservative Treatment Using Hypofractionated Simultaneous Integrated Boost Technique.
    Sundaramoorthy S; Karunanidhi G; Pal P; C SV; Radhakrishnan H
    Gulf J Oncolog; 2024 May; 1(45):15-29. PubMed ID: 38774929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Final analysis of a Multicenter Single-Arm Confirmatory Trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906.
    Nozaki M; Kagami Y; Machida R; Nakamura K; Ito Y; Nishimura Y; Teshima T; Saito Y; Nagata Y; Matsumoto Y; Akimoto T; Hiraoka M;
    Jpn J Clin Oncol; 2021 May; 51(6):865-872. PubMed ID: 33728450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of hypofractionated and conventionally fractionated whole-breast irradiation for early breast cancer patients: a single-institute study of 1,098 patients.
    Karasawa K; Kunogi H; Hirai T; Hojo H; Hirowatari H; Izawa H; Ito K; Sasai K; Kawashima M; Furuya T; Sugimoto S; Kurokawa C; Ozawa S; Saito M
    Breast Cancer; 2014 Jul; 21(4):402-8. PubMed ID: 22968629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-reported Long-term Cosmetic Outcomes Following Short Fractionation Whole Breast Radiotherapy With Boost.
    Chan EK; Tabarsi N; Tyldesley S; Khan M; Woods R; Speers C; Weir L
    Am J Clin Oncol; 2016 Oct; 39(5):473-8. PubMed ID: 24824143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
    Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
    JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute radiation-induced skin toxicity in hypofractionated vs. conventional whole-breast irradiation: An objective, randomized multicenter assessment using spectrophotometry.
    Schmeel LC; Koch D; Schmeel FC; Röhner F; Schoroth F; Bücheler BM; Mahlmann B; Leitzen C; Schüller H; Tschirner S; Fuhrmann A; Heimann M; Brüser D; Abramian AV; Müdder T; Garbe S; Vornholt S; Schild HH; Baumert BG; Wilhelm-Buchstab TM
    Radiother Oncol; 2020 May; 146():172-179. PubMed ID: 32171945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patients.
    Dicuonzo S; Leonardi MC; Raimondi S; Corrao G; Bagnardi V; Gerardi MA; Morra A; Zerella MA; Zaffaroni M; Pansini F; Cattani F; Luraschi R; Fodor C; Veronesi P; Orecchia R; Rojas DP; Jereczek-Fossa BA
    Clin Transl Oncol; 2021 Jul; 23(7):1415-1428. PubMed ID: 33537865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are We Missing Acute Toxicities Associated With Hypofractionated Breast Irradiation? A Report From a Large Multicenter Cohort Study.
    Beydoun H; Griffith KA; Jagsi R; Burmeister JW; Moran JM; Vicini FA; Hayman JA; Paximadis P; Boike TP; Walker EM; Pierce LJ; Dominello MM
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(4):1092-1098. PubMed ID: 38364950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.